Published in J Inorg Biochem on April 28, 2013
Glycolytic enzymes can modulate cellular life span. Cancer Res (2005) 3.78
PTEN, more than the AKT pathway. Carcinogenesis (2007) 2.70
Roscovitine targets, protein kinases and pyridoxal kinase. J Biol Chem (2005) 2.31
Inhibition of HSP90 molecular chaperones: moving into the clinic. Lancet Oncol (2013) 1.84
CBX7 controls the growth of normal and tumor-derived prostate cells by repressing the Ink4a/Arf locus. Oncogene (2005) 1.63
Spinophilin acts as a tumor suppressor by regulating Rb phosphorylation. Cell Cycle (2011) 1.53
Spinophilin loss contributes to tumorigenesis in vivo. Cell Cycle (2011) 1.45
Transcriptional signature of Ecteinascidin 743 (Yondelis, Trabectedin) in human sarcoma cells explanted from chemo-naive patients. Mol Cancer Ther (2005) 1.32
Pim kinases in cancer: diagnostic, prognostic and treatment opportunities. Biochem Pharmacol (2012) 1.31
Immortalization of primary human prostate epithelial cells by c-Myc. Cancer Res (2005) 1.30
Cold-inducible RNA-binding protein bypasses replicative senescence in primary cells through extracellular signal-regulated kinase 1 and 2 activation. Mol Cell Biol (2009) 1.20
The PIM family of serine/threonine kinases in cancer. Med Res Rev (2013) 1.17
Cell cycle deregulation: a common motif in cancer. Prog Cell Cycle Res (2003) 1.14
Membrane localization of all class I PI 3-kinase isoforms suppresses c-Myc-induced apoptosis in Rat1 fibroblasts via Akt. J Cell Biochem (2005) 1.04
Mice expressing myrAKT1 in the mammary gland develop carcinogen-induced ER-positive mammary tumors that mimic human breast cancer. Carcinogenesis (2006) 1.03
Chemical interrogation of FOXO3a nuclear translocation identifies potent and selective inhibitors of phosphoinositide 3-kinases. J Biol Chem (2009) 1.03
Understanding FOXO, new views on old transcription factors. Curr Cancer Drug Targets (2010) 1.01
Activation of phosphatidylinositol 3-kinase by membrane localization of p110alpha predisposes mammary glands to neoplastic transformation. Cancer Res (2008) 0.97
Chemical genetic analysis of FOXO nuclear-cytoplasmic shuttling by using image-based cell screening. Chembiochem (2008) 0.97
Cooperation between Cdk4 and p27kip1 in tumor development: a preclinical model to evaluate cell cycle inhibitors with therapeutic activity. Cancer Res (2005) 0.96
An HTS approach to screen for antagonists of the nuclear export machinery using high content cell-based assays. Assay Drug Dev Technol (2007) 0.95
Mitotic catastrophe cell death induced by heat shock protein 90 inhibitor in BRCA1-deficient breast cancer cell lines. Mol Cancer Ther (2008) 0.94
Levels of p27(kip1) determine Aplidin sensitivity. Mol Cancer Ther (2007) 0.94
Pim 1 kinase inhibitor ETP-45299 suppresses cellular proliferation and synergizes with PI3K inhibition. Cancer Lett (2010) 0.93
MAP17 enhances the malignant behavior of tumor cells through ROS increase. Carcinogenesis (2007) 0.93
DNA methylation signatures identify biologically distinct thyroid cancer subtypes. J Clin Endocrinol Metab (2013) 0.92
MAP17 overexpression is a common characteristic of carcinomas. Carcinogenesis (2007) 0.92
PPP1CA contributes to the senescence program induced by oncogenic Ras. Carcinogenesis (2008) 0.92
Extreme sensitivity to Yondelis (Trabectedin, ET-743) in low passaged sarcoma cell lines correlates with mutated p53. J Cell Biochem (2007) 0.91
Association between the miRNA signatures in plasma and bronchoalveolar fluid in respiratory pathologies. Dis Markers (2012) 0.90
Down-regulation of spinophilin in lung tumours contributes to tumourigenesis. J Pathol (2011) 0.89
Expression of CYP3A4 as a predictor of response to chemotherapy in peripheral T-cell lymphomas. Blood (2007) 0.87
Exploring the gain of function contribution of AKT to mammary tumorigenesis in mouse models. PLoS One (2010) 0.87
Loss-of-function genetic screening identifies a cluster of ribosomal proteins regulating p53 function. Carcinogenesis (2008) 0.87
MAP17 and SGLT1 protein expression levels as prognostic markers for cervical tumor patient survival. PLoS One (2013) 0.86
The essential role of PIM kinases in sarcoma growth and bone invasion. Carcinogenesis (2012) 0.86
Structural characterization, DNA interactions, and cytotoxicity of new transplatin analogues containing one aliphatic and one planar heterocyclic amine ligand. J Med Chem (2006) 0.86
Spinophilin loss correlates with poor patient prognosis in advanced stages of colon carcinoma. Clin Cancer Res (2013) 0.86
Characterization of the p53 response to oncogene-induced senescence. PLoS One (2008) 0.86
The TGF-beta co-receptor endoglin modulates the expression and transforming potential of H-Ras. Carcinogenesis (2010) 0.86
Using multiplexed regulation of luciferase activity and GFP translocation to screen for FOXO modulators. BMC Cell Biol (2009) 0.86
Cellular senescence induced by p53-ras cooperation is independent of p21waf1 in murine embryo fibroblasts. J Cell Biochem (2004) 0.86
MAP17 inhibits Myc-induced apoptosis through PI3K/AKT pathway activation. Carcinogenesis (2007) 0.86
DNA interactions of new antitumor platinum complexes with trans geometry activated by a 2-metylbutylamine or sec-butylamine ligand. Biochem Pharmacol (2004) 0.85
Antitumor and cellular pharmacological properties of a novel platinum(IV) complex: trans-[PtCl(2)(OH)(2)(dimethylamine) (isopropylamine)]. Mol Pharmacol (2003) 0.85
Genetic modelling of the PTEN/AKT pathway in cancer research. Clin Transl Oncol (2008) 0.85
Overexpression of cyclin D1 inhibits TNF-induced growth arrest. J Cell Biochem (2003) 0.85
An androgenic steroid delivery vector that imparts activity to a non-conventional platinum(II) metallo-drug. Dalton Trans (2010) 0.85
Cellular senescence as a target in cancer control. J Aging Res (2010) 0.85
Novel soluble cationic trans-diaminedichloroplatinum(II) complexes that are active against cisplatin resistant ovarian cancer cell lines. J Med Chem (2002) 0.84
Inhibition of phosphatidylinositol-3-kinase synergizes with gemcitabine in low-passage tumor cell lines correlating with Bax translocation to the mitochondria. Anticancer Drugs (2005) 0.84
Mouse models to decipher the PI3K signaling network in human cancer. Curr Mol Med (2009) 0.84
Influence of amine ligands on the aquation and cytotoxicity of trans-diamine platinum(II) anticancer complexes. Dalton Trans (2009) 0.84
Novel transplatinum(II) complexes with [N2O2] donor sets. Cellular pharmacology and apoptosis induction in Pam 212-ras cells. J Med Chem (2006) 0.83
A dual-color fluorescence-based platform to identify selective inhibitors of Akt signaling. PLoS One (2008) 0.83
The preparation and characterization of trans-platinum(IV) complexes with unusually high cytotoxicity. Dalton Trans (2010) 0.83
Identification of oxidative stress related proteins as biomarkers for lung cancer and chronic obstructive pulmonary disease in bronchoalveolar lavage. Int J Mol Sci (2013) 0.82
Inhibiting PI3K as a therapeutic strategy against cancer. Clin Transl Oncol (2009) 0.82
Targeting of p53-transcriptional dysfunction by conditionally replicating adenovirus is not limited by p53-homologues. Mol Ther (2009) 0.81
Conjugation of testosterone modifies the interaction of mono-functional cationic platinum(II) complexes with DNA, causing significant alterations to the DNA helix. Dalton Trans (2010) 0.81
PDGFRα/β and VEGFR2 polymorphisms in colorectal cancer: incidence and implications in clinical outcome. BMC Cancer (2012) 0.81
The role of p53 in the cellular toxicity by active trans-platinum complexes containing isopropylamine and hydroxymethylpyridine. Eur J Med Chem (2009) 0.80
Proteins as possible targets for cytotoxic trans-platinum(II) complexes with aliphatic amine ligands: Further exceptions to the DNA paradigm. ChemMedChem (2010) 0.80
Structure-activity relationship of new trans-platinum(II) and (IV) complexes with cyclohexylamine. Interference with cell cycle progression and induction of cell death. J Inorg Biochem (2006) 0.79
Photoactivation of trans diamine platinum complexes in aqueous solution and effect on reactivity towards nucleotides. J Inorg Biochem (2010) 0.79
Solution behaviour and biomolecular interactions of two cytotoxic trans-platinum(II) complexes bearing aliphatic amine ligands. Chemistry (2009) 0.79
Apoptosis induction and DNA interstrand cross-link formation by cytotoxic trans-[PtCl2(NH(CH3)2)(NHCH(CH3)2) : cross-linking between d(G) and complementary d(C) within oligonucleotide duplexes. Chembiochem (2002) 0.79
Using cells devoid of RAS proteins as tools for drug discovery. Mol Carcinog (2009) 0.79
Inhibition of p38-MAPK potentiates cisplatin-induced apoptosis via GSH depletion and increases intracellular drug accumulation in growth-arrested kidney tubular epithelial cells. Toxicol Sci (2009) 0.78
Conditional transgenic expression of PIM1 kinase in prostate induces inflammation-dependent neoplasia. PLoS One (2013) 0.78
Bypassing cellular senescence by genetic screening tools. Clin Transl Oncol (2010) 0.78
Mst1, RanBP2 and eIF4G are new markers for in vivo PI3K activation in murine and human prostate. Carcinogenesis (2007) 0.77
New trans-platinum drugs with phosphines and amines as carrier ligands induce apoptosis in tumor cells resistant to cisplatin. J Med Chem (2007) 0.77
Trans platinum complexes design: one novel water soluble oxime derivative that contains aliphatic amines in trans configuration. J Inorg Biochem (2006) 0.77
Heterometallic platinum(II) compounds with β-aminoethylferrocenes: synthesis, electrochemical behaviour and anticancer activity. Dalton Trans (2011) 0.77
Three new asymmetric trans-amine(azole)dichloridoplatinum complexes that overcome cisplatin resistance and their reactions with 5'-GMP. J Inorg Biochem (2006) 0.77
MiR-107 and miR-99a-3p predict chemotherapy response in patients with advanced colorectal cancer. BMC Cancer (2014) 0.77
Design and biological evaluation of new platinum(II) complexes bearing ligands with DNA-targeting ability. Inorg Chem (2014) 0.77
Interactions between anticancer trans-platinum compounds and proteins: crystal structures and ESI-MS spectra of two protein adducts of trans-(dimethylamino)(methylamino)dichloridoplatinum(II). Inorg Chem (2014) 0.77
Expanding the synthesis of new trans-sulfonamide platinum complexes: cytotoxicity, SAR, fluorescent cell assays and stability studies. J Inorg Biochem (2013) 0.76
Tandem cyclization-Michael reaction by combination of metal- and organocatalysis. J Org Chem (2011) 0.76
Reactivity and biological properties of a series of cytotoxic PtI2(amine)2 complexes, either cis or trans configured. Inorg Chem (2012) 0.76
EMX homeobox genes regulate microphthalmia and alter melanocyte biology. Exp Cell Res (2005) 0.76
Cancer, senescence, and aging: translation from basic research to clinics. J Aging Res (2011) 0.76